Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01478321
Title Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

high grade glioma

glioblastoma

Therapies

Bevacizumab + Temozolomide

Age Groups: adult
Covered Countries USA


No variant requirements are available.